MedTrace Logo

MicroRNA-150 and microRNA-155 in Multiple Sclerosis

NCT04300543 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 140

Last updated 2020-03-09

No results posted yet for this study

Summary

A study To analyse the expression of circulating miR-150 and miR-155 in serum of MS patients, Evaluate the serum levels of oligoclonal bands, neurofilaments and chitinase-3-like-1 in serum of MS patients, and Investigate the correlation between the measured biomarkers and each other and their correlation with different MS phenotypes , disability status and the patients demographic data.

Conditions

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Sahar Eldeek, Ph.D. · Assiut University

  • Sally Mohamed · Assiut University

  • Lamia Ahmed · Assiut University

Eligibility

Min Age
18 Years
Max Age
68 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-04-30
Primary Completion
2021-04-30
Completion
2021-10-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04300543 on ClinicalTrials.gov